Reporting Manager
Point72 Asset Management, L.P.
Symbol
TENX
Shares outstanding
4,589,635 shares
Disclosed Ownership
339,633 shares
Ownership
7.4%
Form type
SCHEDULE 13G
Filing time
29 Oct 2025, 17:29:57 UTC
Date of event
22 Oct 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 7.4% ownership in TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX) on 22 Oct 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX).
  • Disclosed ownership: 7.4%.
  • Date of event: 22 Oct 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 29 Oct 2025, 17:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 7.4% 339,633 0 339,633 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 7.4% 339,633 0 339,633 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 7.4% 339,633 0 339,633 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person